CEGEDIM SA (CGM.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:CGM - FR0000053506 - Common Stock
10.4 EUR
-0.2 (-1.89%)
Taking everything into account, CGM scores 3 out of 10 in our fundamental rating. CGM was compared to 10 industry peers in the Health Care Technology industry. Both the profitability and financial health of CGM have multiple concerns. CGM has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
CGM had negative earnings in the past year.
CGM had a positive operating cash flow in the past year.
In multiple years CGM reported negative net income over the last 5 years.
CGM had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -1.49%, CGM perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
CGM has a Return On Equity (-5.56%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 4.46%, CGM is in line with its industry, outperforming 45.45% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CGM is significantly below the industry average of 9.28%.
The 3 year average ROIC (2.87%) for CGM is below the current ROIC(4.46%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.49% | ||
| ROE | -5.56% | ||
| ROIC | 4.46% |
ROA(3y)-0.25%
ROA(5y)0.74%
ROE(3y)-1.16%
ROE(5y)2.61%
ROIC(3y)2.87%
ROIC(5y)3.89%
1.3 Margins
With a Operating Margin value of 5.75%, CGM perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
CGM's Operating Margin has declined in the last couple of years.
CGM's Gross Margin of 20.07% is on the low side compared to the rest of the industry. CGM is outperformed by 81.82% of its industry peers.
CGM's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.75% | ||
| PM (TTM) | N/A | ||
| GM | 20.07% |
OM growth 3Y-6.64%
OM growth 5Y-3.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.96%
GM growth 5Y-1.7%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CGM is still creating some value.
Compared to 1 year ago, CGM has more shares outstanding
The number of shares outstanding for CGM has been reduced compared to 5 years ago.
Compared to 1 year ago, CGM has a worse debt to assets ratio.
2.2 Solvency
CGM has an Altman-Z score of 1.27. This is a bad value and indicates that CGM is not financially healthy and even has some risk of bankruptcy.
CGM's Altman-Z score of 1.27 is in line compared to the rest of the industry. CGM outperforms 45.45% of its industry peers.
CGM has a debt to FCF ratio of 27.31. This is a negative value and a sign of low solvency as CGM would need 27.31 years to pay back of all of its debts.
CGM has a Debt to FCF ratio (27.31) which is in line with its industry peers.
CGM has a Debt/Equity ratio of 1.14. This is a high value indicating a heavy dependency on external financing.
CGM's Debt to Equity ratio of 1.14 is on the low side compared to the rest of the industry. CGM is outperformed by 72.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 27.31 | ||
| Altman-Z | 1.27 |
ROIC/WACC1.08
WACC4.14%
2.3 Liquidity
A Current Ratio of 0.99 indicates that CGM may have some problems paying its short term obligations.
The Current ratio of CGM (0.99) is worse than 63.64% of its industry peers.
CGM has a Quick Ratio of 0.99. This is a bad value and indicates that CGM is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CGM (0.97) is worse than 63.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.99 | ||
| Quick Ratio | 0.97 |
3. Growth
3.1 Past
CGM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -97.97%.
The Revenue has been growing slightly by 6.25% in the past year.
CGM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.38% yearly.
EPS 1Y (TTM)-97.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1194.13%
Revenue 1Y (TTM)6.25%
Revenue growth 3Y7.65%
Revenue growth 5Y5.38%
Sales Q2Q%6.51%
3.2 Future
Based on estimates for the next years, CGM will show a very strong growth in Earnings Per Share. The EPS will grow by 21.86% on average per year.
The Revenue is expected to grow by 3.41% on average over the next years.
EPS Next Y-1.77%
EPS Next 2Y20.1%
EPS Next 3Y21.86%
EPS Next 5YN/A
Revenue Next Year1.46%
Revenue Next 2Y2.88%
Revenue Next 3Y3.41%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CGM. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 9.28, the valuation of CGM can be described as reasonable.
CGM's Price/Forward Earnings ratio is rather cheap when compared to the industry. CGM is cheaper than 90.91% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.46. CGM is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 9.28 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CGM is valued cheaper than 100.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CGM indicates a rather cheap valuation: CGM is cheaper than 90.91% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.29 | ||
| EV/EBITDA | 3.23 |
4.3 Compensation for Growth
A more expensive valuation may be justified as CGM's earnings are expected to grow with 21.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.1%
EPS Next 3Y21.86%
5. Dividend
5.1 Amount
CGM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:CGM (9/3/2025, 7:00:00 PM)
10.4
-0.2 (-1.89%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners17.29%
Inst Owner ChangeN/A
Ins Owners57.12%
Ins Owner ChangeN/A
Market Cap146.64M
Revenue(TTM)654.50M
Net Income(TTM)-14.71M
Analysts48.89
Price Target12.92 (24.23%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.56%
PT rev (3m)-7.32%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-24.49%
EPS NY rev (3m)-24.49%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 9.28 | ||
| P/S | 0.22 | ||
| P/FCF | 12.29 | ||
| P/OCF | 1.44 | ||
| P/B | 0.55 | ||
| P/tB | N/A | ||
| EV/EBITDA | 3.23 |
EPS(TTM)-1.07
EYN/A
EPS(NY)1.12
Fwd EY10.78%
FCF(TTM)0.85
FCFY8.14%
OCF(TTM)7.22
OCFY69.45%
SpS46.42
BVpS18.75
TBVpS-11.55
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.49% | ||
| ROE | -5.56% | ||
| ROCE | 6.06% | ||
| ROIC | 4.46% | ||
| ROICexc | 4.84% | ||
| ROICexgc | 19.22% | ||
| OM | 5.75% | ||
| PM (TTM) | N/A | ||
| GM | 20.07% | ||
| FCFM | 1.82% |
ROA(3y)-0.25%
ROA(5y)0.74%
ROE(3y)-1.16%
ROE(5y)2.61%
ROIC(3y)2.87%
ROIC(5y)3.89%
ROICexc(3y)3.13%
ROICexc(5y)4.15%
ROICexgc(3y)11.62%
ROICexgc(5y)15.26%
ROCE(3y)3.91%
ROCE(5y)5.29%
ROICexgc growth 3Y0.21%
ROICexgc growth 5Y-3.19%
ROICexc growth 3Y-3.24%
ROICexc growth 5Y-2.52%
OM growth 3Y-6.64%
OM growth 5Y-3.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.96%
GM growth 5Y-1.7%
F-Score3
Asset Turnover0.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 27.31 | ||
| Debt/EBITDA | 2.3 | ||
| Cap/Depr | 96.22% | ||
| Cap/Sales | 13.74% | ||
| Interest Coverage | 4.24 | ||
| Cash Conversion | 77.7% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.99 | ||
| Quick Ratio | 0.97 | ||
| Altman-Z | 1.27 |
F-Score3
WACC4.14%
ROIC/WACC1.08
Cap/Depr(3y)92.57%
Cap/Depr(5y)94.88%
Cap/Sales(3y)13.24%
Cap/Sales(5y)13.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-97.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1194.13%
EPS Next Y-1.77%
EPS Next 2Y20.1%
EPS Next 3Y21.86%
EPS Next 5YN/A
Revenue 1Y (TTM)6.25%
Revenue growth 3Y7.65%
Revenue growth 5Y5.38%
Sales Q2Q%6.51%
Revenue Next Year1.46%
Revenue Next 2Y2.88%
Revenue Next 3Y3.41%
Revenue Next 5YN/A
EBIT growth 1Y79.81%
EBIT growth 3Y0.5%
EBIT growth 5Y1.66%
EBIT Next Year278.79%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-46.81%
FCF growth 3Y-27.43%
FCF growth 5YN/A
OCF growth 1Y4.01%
OCF growth 3Y2%
OCF growth 5Y28.33%
CEGEDIM SA / CGM.PA FAQ
What is the fundamental rating for CGM stock?
ChartMill assigns a fundamental rating of 3 / 10 to CGM.PA.
Can you provide the valuation status for CEGEDIM SA?
ChartMill assigns a valuation rating of 5 / 10 to CEGEDIM SA (CGM.PA). This can be considered as Fairly Valued.
What is the profitability of CGM stock?
CEGEDIM SA (CGM.PA) has a profitability rating of 3 / 10.
How sustainable is the dividend of CEGEDIM SA (CGM.PA) stock?
The dividend rating of CEGEDIM SA (CGM.PA) is 0 / 10 and the dividend payout ratio is 0%.